2-hydroxypropyl-beta-cyclodextrin treatment does not induce atherosclerotic lesion regression in western-type diet-fed apolipoprotein e knockout mice

HIGHLIGHTS

  • who: Olga S.C. Snip and colleagues from the Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, CC Leiden, The Netherlands have published the paper: 2-Hydroxypropyl-beta-cyclodextrin Treatment Does Not Induce Atherosclerotic Lesion Regression in Western-Type Diet-Fed Apolipoprotein E Knockout Mice, in the Journal: Biomolecules 2022, 12, 1205. of /2022/
  • what: The authors therefore also investigated the ability of 2HPu03b2CD to stimulate cholesterol removal from macrophage foam cells in vitro and induce the regression of established atherosclerotic lesions in_(APOE KO) With this study the authors aimed to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?